Synopsis
0
USDMF
0
CEP/COS
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Asta C 4898
2. Biopropazepan Trimethoxybenzoate
3. C 4898, Asta
4. Dilazep
5. Trimethoxybenzoate, Biopropazepan
1. Dilazep Dihydrochloride
2. 20153-98-4
3. Dilazep (dihydrochloride)
4. Asta C 4898
5. Prestwick_175
6. Lv48lw10eo
7. 1,4-bis[3-(3,4,5-trimethoxybenzoyloxy)propyl]homopiperazine Dihydrochloride
8. Nsc-760096
9. Sr-01000075817
10. (tetrahydro-1h-1,4-diazepine-1,4(5h)-diyl)di(propane-1,3-diyl) Bis(3,4,5-trimethoxybenzoate) Dihydrochloride
11. 1,4-bis(3-(3,4,5-trimethoxybenzoyloxy)propyl)homopiperazine Dihydrochloride
12. Mfcd00133267
13. 3-[4-[3-(3,4,5-trimethoxybenzoyl)oxypropyl]-1,4-diazepan-1-yl]propyl 3,4,5-trimethoxybenzoate
14. Surecn349239
15. Schembl349239
16. Dilazep Dihydrochloride, Powder
17. Chembl1603820
18. Chebi:31493
19. Hms1568p13
20. Dilazep Dihydrochloride [mi]
21. Akos024458358
22. Ccg-213812
23. Dilazep Dihydrochloride [who-dd]
24. 3-[4-[3-(3,4,5-trimethoxybenzoyl)oxypropyl]-1,4-diazepan-1-yl]propyl 3,4,5-trimethoxybenzoate;dihydrochloride
25. As-82736
26. Hy-100957
27. Cs-0020636
28. Sr-01000075817-1
29. Sr-01000075817-6
30. W-110510
31. Q27283203
32. (1,4-diazepane-1,4-diyl)bis(propane-3,1-diyl) Bis(3,4,5-trimethoxybenzoate) Dihydrochloride
33. 3-{4-[3-(3,4,5-trimethoxybenzoyloxy)propyl]-1,4-diazepan-1-yl}propyl 3,4,5-trimethoxybenzoate Dihydrochloride
Molecular Weight | 677.6 g/mol |
---|---|
Molecular Formula | C31H46Cl2N2O10 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 12 |
Rotatable Bond Count | 18 |
Exact Mass | 676.2529511 g/mol |
Monoisotopic Mass | 676.2529511 g/mol |
Topological Polar Surface Area | 115 Ų |
Heavy Atom Count | 45 |
Formal Charge | 0 |
Complexity | 727 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 3 |
Vasodilator Agents
Drugs used to cause dilation of the blood vessels. (See all compounds classified as Vasodilator Agents.)
ABOUT THIS PAGE
A Dilazep manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Dilazep, including repackagers and relabelers. The FDA regulates Dilazep manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Dilazep API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Dilazep manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Dilazep supplier is an individual or a company that provides Dilazep active pharmaceutical ingredient (API) or Dilazep finished formulations upon request. The Dilazep suppliers may include Dilazep API manufacturers, exporters, distributors and traders.
click here to find a list of Dilazep suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Dilazep Drug Master File in Japan (Dilazep JDMF) empowers Dilazep API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Dilazep JDMF during the approval evaluation for pharmaceutical products. At the time of Dilazep JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Dilazep suppliers with JDMF on PharmaCompass.
Dilazep Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Dilazep GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Dilazep GMP manufacturer or Dilazep GMP API supplier for your needs.
A Dilazep CoA (Certificate of Analysis) is a formal document that attests to Dilazep's compliance with Dilazep specifications and serves as a tool for batch-level quality control.
Dilazep CoA mostly includes findings from lab analyses of a specific batch. For each Dilazep CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Dilazep may be tested according to a variety of international standards, such as European Pharmacopoeia (Dilazep EP), Dilazep JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Dilazep USP).
LOOKING FOR A SUPPLIER?